We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.38B
1-Year Est. Return
63.08%
This Fund
S&P 500
This Quarter
Est. Return
+9.23%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.22B
AUM Growth
+$2.7B
(+177%)
Cap. Flow
+$3.76B
Cap. Flow
% of AUM
89.24%
Top 10 Holdings %
Top 10 Hldgs %
40.53%
Holding
623
New
593
Increased
5
Reduced
1
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
OSH
Oak Street Health, Inc.
OSH
|
+$211M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$189M |
| 3 |
UNVR
Univar Solutions Inc.
UNVR
|
+$175M |
| 4 |
MAXR
Maxar Technologies Inc. Common Stock
MAXR
|
+$143M |
| 5 |
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$196M |
| 2 |
SGFY
Signify Health, Inc.
SGFY
|
+$161M |
| 3 |
ONEM
1Life Healthcare
ONEM
|
+$141M |
| 4 |
TGNA
TEGNA Inc
TGNA
|
+$46.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 22.21% |
| 2 | Healthcare | 21.36% |
| 3 | Technology | 18.59% |
| 4 | Industrials | 5.57% |
| 5 | Real Estate | 5.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Arbor Realty Trust
ABR
$994M
| $1.43M | 0.03% |
+124,176
| New | +$1.72M |
|
|
CTLT
352
DELISTED
CATALENT, INC.
CTLT
| $1.42M | 0.03% |
+21,576
| New | +$1.33M |
|
353
PUT
Nabors Industries
NBR
$1.21B
| $1.41M | 0.03% |
+41,900
| New | +$6.35M |
|
354
SunPower Inc
SPWR
$50M
| $1.41M | 0.03% |
+136,747
| New | +$1.4M |
|
|
AUTL
355
Autolus Therapeutics
AUTL
$543M
| $1.39M | 0.03% |
+757,008
| New | +$1.48M |
|
356
Axsome Therapeutics
AXSM
$10.9B
| $1.39M | 0.03% |
+22,566
| New | +$1.48M |
|
|
ATVI
357
CALL
DELISTED
Activision Blizzard
ATVI
| $1.37M | 0.03% |
+533,700
| New | +$41.5M |
|
358
Icon
ICLR
$12.6B
| $1.35M | 0.03% |
+6,318
| New | +$1.41M |
|
|
HLVX
359
DELISTED
HilleVax
HLVX
| $1.34M | 0.03% |
+81,267
| New | +$1.3M |
|
360
Twilio
TWLO
$36.9B
| $1.33M | 0.03% |
+20,000
| New | +$1.23M |
|
|
LTC
361
LTC Properties
LTC
$2.13B
| $1.26M | 0.03% |
+35,776
| New | +$1.29M |
|
362
EPR Properties
EPR
$4.72B
| $1.24M | 0.03% |
+32,656
| New | +$1.3M |
|
363
Albemarle
ALB
$15.1B
| $1.24M | 0.03% |
+5,616
| New | +$1.38M |
|
|
TRIS
364
DELISTED
Tristar Acquisition I Corp.
TRIS
| $1.23M | 0.03% |
+119,545
| New | +$1.23M |
|
365
Tarsus Pharmaceuticals
TARS
$2.91B
| $1.23M | 0.03% |
+98,175
| New | +$1.44M |
|
366
Agios Pharmaceuticals
AGIO
$1.91B
| $1.21M | 0.03% |
+52,500
| New | +$1.39M |
|
367
Roivant Sciences
ROIV
$26B
| $1.19M | 0.03% |
+161,825
| New | +$1.33M |
|
368
Procept Biorobotics
PRCT
$1.16B
| $1.19M | 0.03% |
+41,943
| New | +$1.48M |
|
|
MORF
369
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $1.15M | 0.03% |
+30,552
| New | +$1.13M |
|
370
Acadia Realty Trust
AKR
$2.88B
| $1.15M | 0.03% |
+82,368
| New | +$1.19M |
|
371
Zoom
ZM
$30.8B
| $1.11M | 0.03% |
+15,000
| New | +$1.08M |
|
372
Viking Therapeutics
VKTX
$3.9B
| $1.09M | 0.03% |
+65,608
| New | +$678K |
|
373
Savara
SVRA
$1.2B
| $1.09M | 0.03% |
+556,513
| New | +$1.25M |
|
374
Scholar Rock
SRRK
$6.32B
| $1.08M | 0.03% |
+135,556
| New | +$1.38M |
|
375
Orthofix Medical
OFIX
$421M
| $1.08M | 0.03% |
+64,680
| New | +$1.27M |
|
Similar funds
FNBT
SAG
ACI
TCOV
RC
A
CGL
CB
UBS O'Connor's Q1 2023 Portfolio in Review
As of Q1 2023, UBS O'Connor held 623 positions worth $4.22B, up 177% from $1.52B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
UBS O'Connor deployed $3.76B of net new capital in Q1 2023, opening 593 new positions and adding to 5 existing holdings. Its largest new stake was Oak Street Health, Inc.: 6,537,297 shares worth $25.3M.
By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Activision Blizzard, an estimated $196M trimmed.
- UBS O'Connor's largest Q1 2023 buy was Oak Street Health, Inc.: 6,537,297 shares worth $25.3M.
- UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $189M increase.
- UBS O'Connor's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $196M.
- UBS O'Connor fully exited Signify Health, Inc. in Q1 2023, selling an estimated $161M.
- UBS O'Connor's ten largest holdings make up 41% of its $4.22B portfolio in Q1 2023.
- UBS O'Connor opened 593 new positions and closed 3 in Q1 2023.
- UBS O'Connor's portfolio value rose 177% quarter-over-quarter to $4.22B.
Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.